Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

Virology

Volumn 219, Issue 1, 1996, Pages 37-44

  Kirnbauer, R ^a   Chandrachud, L M ^b   O'Neil, B W ^b   Wagner, E R ^c   Grindlay, G J ^c   Armstrong, A ^a   McGarvie, G M ^c   Schiller, J T ^d   Lowy, D R ^d   Campo, M S ^c  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED STUDY; COW; CROSS REACTION; IMMUNIZATION; MOLECULAR CLONING; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION; VIRUS PARTICLE;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 4; BOVINE PARVOVIRUS; INSECTA; MIRIDAE; PAPILLOMAVIRUS;

EID: 0030001427     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0220     Document Type: Article

References (35)

1. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., TrinDinh-Desmarquet, C., Orth, G., Schiller, J. T., and Lowy, D. R. (1995). Immunization with virus-like particles from cottontail papillomavirus can protect against experimental CRPV infection. J. Virol. 69, 3959-3963.
2. Campo, M. S., and Coggins, L. W. (1982). Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homology by heteroduplex mapping. J. Gen. Virol. 63, 255-264.
3. Campo, M. S., Grindlay, G. J., O'Neil, B. W., Chandrachud, L. M., McGarvie, G. M., and Jarrett, W. F. H. (1993a). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J. Gen. Virol. 74, 945-953.
4. Campo, M. S., O'Neil, B. W., Barron, R. J., and Jarrett, W. F. H. (1993b). Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 15, 1597-1601.
5. Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M., O'Neil, B. W., Wagner, E. R., Jarrett, W. F. H., and Campo, M. S. (1995). Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology 211, 204-208.
6. Chandrachud, L. M., O'Neil, B. W., Jarrett, W. F. H., Grindlay, G. J., McGarvie, G. M., and Campo, M. S. (1994). Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. Virology 200, 98-104.
7. Christensen, N. D., Hopfl, R., DiAngelo, S. L., Cladel, N. M., Patrick, S. D., Welsh, P. A., Budgeon, L. R., Reed, C. A., and Kreider, J. W. (1994a). Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognised by neutralising monoclonal antibodies and induce high titres of neutralising antibodies. J. Gen. Virol. 75, 2271-2276.
8. Christensen, N. D., Kirnbauer, R., Schiller, J. T., Ghim, S-J., Schlegel, R., Jenson, A. B., and Kreider, J. W. (1994b). Human papillomavirus type 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralising epitopes. Virology 205, 329-335.
9. Christensen, N. D., Kreider, J. W., Kan, N. C., and DiAngelo, S. L. (1991). The open reading frame L2 of cottontail rabbit papillomavirus contai ns antibody-inducing neutralizing epitopes. Virology 181, 572-579.
10. Gaukroger, J. M., Chaudrachud, L. M., O'Neil, B. W., Grindlay, G. J., Knowles, G., and Campo, M. S. (1996). Vaccination of cattle with BPV-UL2 elicits the production of virus neutrolising antibodies. J. Gen. Virol., in press.
11. Ghim, S., Christensen, N. D., Kreider, J. W., and Jenson, A. B. (1991). Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int. J. Cancer 49, 285-289.
12. Ghim, S., Young, R., and Jenson, A. B. (1996). Antigenicity of bovine papillomavirus type 1 virus-like particles compared with that of intact BPV-1 virions. J. Gen. Virol. 77, 183-188.
13. Hagensee, M. E., Olson, N. H., Baker, T. S., and Galloway, D. A. (1994). Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 68, 4503-4505.
14. Hagensee, M. E., Yaegashi, N., and Galloway, D. A. (1993). Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67, 315-322.
15. IARC, (1995). "IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 64: Human Papillomaviruses." IARC Press.
16. Jarrett, W. F. H., O'Neil, B. W., Gaukroger, J. M., Laird, H. M., Smith, K. T., and Campo, M. S. (1990). Studies on vaccination against papillomaviruses: A comparison of purified virus, tumor extract and transformed cells in prophylactic vaccination. Vet. Rec. 126, 449-452.
17. Jarrett, W. F. H., Smith, K. T., O'Neil, B. W., Gaukroger, J. M., Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M., and Campo, M. S. (1991). Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184, 33-42.
18. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., and Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. 89, 12180-12184.
19. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R., and Schiller, J. T. (1994). A virus-like particle enzyme-linked immunoabsorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. 86, 494-499.
20. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D. R., and Schiller, J. T. (1993). Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67, 6929-6936.
21. Lin, Y-L., Borenstein, L. A., Selvakumar, R., Ahmed, R., and Wettstein, F. O. (1992). Effective vaccination against papilloma development by immunization with L1 or L2 structural proteins of cottontail rabbit papillomavirus. Virology 187, 612-619.
22. Lowy, D. R., Kirnbauer, R., and Schiller, J. T. (1994). Genital human papillomavirus infection. Proc. Natl. Acad. Sci. 91, 2436-2440.
23. McGarvie, G. M., Chandrachud, L. M., Gaukroger, J. M., Grindlay, G. J., O'Neil, B. W., Baird, J. W., Wagner, E. R., Jarrett, W. F. H., and Campo, M. S. (1994). Vaccination of cattle with L2 protein prevents BPV-4 infection. In "Immunology of Papillomaviruses," (M. A. Stanley, Ed.), pp. 283-290. Plenum Press, New York.
24. McGarvie, G. M., Grindlay, G. J., Chandrachud, L. M., O'Neil, B. W., Jarrett, W. F. H., and Campo, M. S. (1995). T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. Virology 206, 504-510.
25. Olson, C., Segre, D., and Skidmore, L. V. (1960). Further observations on immunity to bovine cutaneous papillomatosis. Am. J. Vet. Res. 21, 233-242.
26. Olson, C., and Skidmore, L. V. (1959). Therapy of experimentally produced bovine cutaneous papillomatosis with vaccines and excision. J. Am. Vet. Med. Assoc. 135, 339-343.
27. Pilachinski, W. P., Glassman, D. L., Glassman, K. F., Reed, D. E., Lum, M. A., Marshall, R. F., Muscoplat, C. C., and Faras, A. J. (1986). Immunization against bovine papillomavirus infection. Ciba Found. Symp. 120, 136-148.
28. Roche, J. K., and Crum, C. P. (1991). Local immunity and the uterine cervix: Implications for cancer-associated viruses. Cancer Immunol. Immunother. 33, 203-209.
29. Rose, R. C., Bonnez, W., Reichman, R. C., and Garcea, R. L. (1993). Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67, 1936-1944.
30. Selvakumar, R., Ahmed, R., and Wettstein, F. O. (1995a). Tumour regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus. Virology 208, 298-302.
31. Selvakumar, R., Borenstein, L. A., Lin, Y-L., Ahmed, R., and Wettstein, F. O. (1995b). Immunisation with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J. Virol. 69, 602-605.
32. Shope, R. E. (1937). Immunization of rabbits to infectious papillomatosis. J. Exper. Med. 65, 219-231.
33. Suzich, J. A., Ghim, S-J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., and Schlegel, R. (1995). Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. 92, 11553-11557.
34. Zhou, J., Stenzel, D. J., Sun, X-Y., and Frazer, I. H. (1993). Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J. Gen. Virol. 74, 763-768.
35. Zhou, J., Sun, X. Y., Stenzel, D. J., and Frazer, I. H. (1991). Expression of vaccinia recombinant HPV16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185, 251-257.